About the Company
The Bristol-Myers Squibb Company is an American multinational pharmaceutical company. Headquartered in New York City, BMS is one of the worlds largest pharmaceutical companies and consistently ranks on the Fortune 500 list of the largest U.S. corporations. For fiscal 2022, it had a total revenue of $46.2 billion.
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $BMY News
Bristol-Myers Squibb Is Not A Buy For Me
Key BMY program revenue is at risk from loss of patent exclusivity over the next several years. The company has turned to ...
Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics, Strengthening Neuroscience Portfolio
Bristol Myers Squibb (NYSE: BMY) today announced that it has successfully completed its acquisition of Karuna Therapeutics, ...
Bristol Myers Squibb and Ted Danson Empower Those with Plaque Psoriasis to Take Action in "SO, Have You Found It?" Campaign
NYSE:BMY) Bristol Myers Squibb and Ted Danson Empower Those with Plaque Psoriasis to Take Action in "SO, Have You Found It?" ...
Bristol-Myers Squibb Earnings: BMY Stock Bounces on Strong Q2, Guidance
Bristol-Myers Squibb (NYSE:BMY) reported earnings per share of $1.18 for the second quarter of 2019. This is better than the ...
Hold Rating on Bristol-Myers Squibb Amidst NSCLC Trial Uncertainties and Pending KarXT Results
Leerink Partners analyst David Risinger has maintained their neutral stance on BMY stock, giving a Hold rating yesterday. David Risinger has ...
Perspective Therapeutics Inks Clinical Trial Collaboration Agreement With Bristol Myers
(RTTNews) - Radiopharmaceutical company Perspective Therapeutics, Inc. (CATX) announced Tuesday a clinical trial collaboration agreement with Bristol Myers Squibb Co. (BMY) to evaluate the safety and ...
Bristol Myers Squibb cell therapy gets FDA green light to treat common type of leukemia
Bristol Myers Squibb’s cell therapy Breyanzi won FDA approval Thursday for treatment of a common type of leukemia.
Bristol Myers Squibb closes $14B Karuna deal
Bristol Myers Squibb said it completed its previously announced acquisition of Karuna Therapeutics Inc. – a Boston-based ...
Bristol Myers Wins FDA Approval of CAR-T for Some Blood Cancers
Bristol Myers Squibb Co. won accelerated approval for the first CAR-T therapy for adults with two forms of hard-to-treat ...
Bristol-Myers Squibb Co BMY
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Bristol Myers Squibb Completes Acquisition of Karuna Therapeutics
Bristol Myers Squibb (BMS) has successfully completed its acquisition of Karuna Therapeutics, Inc. Through this transaction, ...
Bristol-Myers Squibb Co
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
Loading the latest forecasts...